Next steps in research on injection initiation incidence and prevention

被引:14
作者
Bluthenthal, Ricky N. [1 ]
Kral, Alex H. [2 ]
机构
[1] Univ So Calif, Keck Sch Med, Dept Prevent Med, Inst Prevent Res, Los Angeles, CA 90033 USA
[2] RTI Int, Behav & Urban Hlth Program, San Francisco, CA USA
关键词
HIV; injection drug use; injection initiation; prescription drug misuse; preventing injection; time to injection initiation; DRUG INJECTION; EPIDEMIOLOGY; MISUSE; HIV;
D O I
10.1111/add.13001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
引用
收藏
页码:1258 / 1259
页数:2
相关论文
共 19 条
  • [1] [Anonymous], 2014, RES 2013 NAT SURV DR
  • [2] [Anonymous], 2015, MMWR-MORBID MORTAL W, V64, P443
  • [3] Bluthenthals R. N., 2013, DRUG ALCOHOL DEPEN, V140, pe15
  • [4] Meth/amphetamine use and associated HIV: Implications for global policy and public health
    Degenhardt, Louisa
    Mathers, Bradley
    Guarinieri, Mauro
    Panda, Samiran
    Phillips, Benjamin
    Strathdee, Steffanie A.
    Tyndall, Mark
    Wiessing, Lucas
    Wodak, Alex
    Howard, John
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2010, 21 (05) : 347 - 358
  • [5] DESJARLAIS DC, 1992, BRIT J ADDICT, V87, P493
  • [6] Epidemiology of inhalant use
    Elena Medina-Mora, Maria
    Real, Tania
    [J]. CURRENT OPINION IN PSYCHIATRY, 2008, 21 (03) : 247 - 251
  • [7] Illicit use of opioids:: Is OxyContin® a "Gateway drug''?
    Grau, Lauretta E.
    Dasgupta, Nabarun
    Harvey, Alison Phinney
    Irwin, Kevin
    Givens, Anthony
    Kinzly, Mark L.
    Heimer, Robert
    [J]. AMERICAN JOURNAL ON ADDICTIONS, 2007, 16 (03) : 166 - 173
  • [8] Evaluation of a brief intervention to prevent initiation into injecting
    Hunt, N
    Stillwell, G
    Taylor, C
    Griffiths, P
    [J]. DRUGS-EDUCATION PREVENTION AND POLICY, 1998, 5 (02) : 185 - 194
  • [9] Heroin use and heroin use risk behaviors among nonmedical users of prescription opioid pain relievers - United States, 2002-2004 and 2008-2010
    Jones, Christopher M.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2013, 132 (1-2) : 95 - 100
  • [10] Kecojevics A., 2015, INT J DRUG POLICY